강민용 교수, 조교수
#신장암#전립선암#방광암#신우암#요관암#고환암#음경암#로봇수술#복강경수술#전립선비대증#혈뇨
|
학력
2014.08 카이스트 의과학대학원 박사
2010.02 서울대학교 의과대학 대학원, 석사
2005.02 서울대학교 의과대학 의학과 학사
2010.02 서울대학교 의과대학 대학원, 석사
2005.02 서울대학교 의과대학 의학과 학사
경력
2019.09 ~현재 삼성융합의과학원(SAHIST) 융합의과학과 겸직 교수
2019.03 ~현재 성균관의대, 삼성서울병원 비뇨의학과 조교수
2019.04 ~ 2019.04 Havard Medical School, Boston Children’s Hospital (Boston, MA, USA) 연수
2018.03 ~ 2019.02 삼성서울병원 비뇨의학과 전임대우조교수
2017.03 ~ 2018.02 삼성서울병원 비뇨의학과 임상전임강사
2016.03 ~ 2017.02 서울대학교병원 비뇨의학과 임상강사
2015.03 ~ 2016.02 분당서울대학교병원 비뇨의학과 임상강사
2014.05 ~ 2015.02 서울대학교병원 비뇨의학과 임상강사
2010.03 ~ 2014.04 KAIST 생명과학과 발생분화연구실 연구원 (전문연구요원)
2010.03 비뇨의학과 전문의 자격 취득
2006.03 ~ 2010.02 서울대학교병원 비뇨의학과 전공의
2009.06 Johns Hopkins Hospital (Baltimore, Maryland, USA) 연수
2005.03 ~ 2006.02 서울대학교병원 인턴 (수련의)
2019.03 ~현재 성균관의대, 삼성서울병원 비뇨의학과 조교수
2019.04 ~ 2019.04 Havard Medical School, Boston Children’s Hospital (Boston, MA, USA) 연수
2018.03 ~ 2019.02 삼성서울병원 비뇨의학과 전임대우조교수
2017.03 ~ 2018.02 삼성서울병원 비뇨의학과 임상전임강사
2016.03 ~ 2017.02 서울대학교병원 비뇨의학과 임상강사
2015.03 ~ 2016.02 분당서울대학교병원 비뇨의학과 임상강사
2014.05 ~ 2015.02 서울대학교병원 비뇨의학과 임상강사
2010.03 ~ 2014.04 KAIST 생명과학과 발생분화연구실 연구원 (전문연구요원)
2010.03 비뇨의학과 전문의 자격 취득
2006.03 ~ 2010.02 서울대학교병원 비뇨의학과 전공의
2009.06 Johns Hopkins Hospital (Baltimore, Maryland, USA) 연수
2005.03 ~ 2006.02 서울대학교병원 인턴 (수련의)
논문
J HEPATOL 2020 10.1016/j.jhep.2020.01.010
Functions of human liver CD69(+)CD103(-)CD8(+) T cells depend on HIF-2 alpha activity in healthy and pathologic livers
Kim1, JH; Han, JW; Choi, YJ; Rha, MS; Koh, JY; Kim, KH; Kim, CG; Lee, YJ; Kim, AR; Park, J; Kim, HK; Min, BS; Il Seo, S; Kang, M; Park, HJ; Han, DH; Il Kim, S; Kim, MS; Lee, JG; Lee, DH; Kim, W; Park, JY; Park, SH; Joo, DJ; Shin, EC
INVESTIG CLIN UROL 2020 10.4111/icu.2020.61.1.19
Enzalutamide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: A retrospective Korean multicenter study in a real-world setting
Jung1, SI; Kim, MS; Jeong, CW; Kwak, C; Hong, SK; Kang, SH; Joung, JY; Lee, SH; Yun, SJ; Kim, TH; Park, SW; Jeon, SS; Kang, M; Lee, JY; Chung, BH; Hong, JH; Ahn, H; Kim, CS; Kwon, DD
CLIN GENITOURIN CANC 2019 10.1016/j.clgc.2019.07.014
Novel Predictive Models of Early Death Less Than 1 Year in Patients With Metastatic Renal Cell Carcinoma After Treatment With First-line Tyrosine Kinase Inhibitors
Shin1, SJ; Kim, T; Sung, HH; Jeon, HG; Jeong, BC; Park, SH; Jeon, SS; Lee, HM; Choi, HY; Seo, SI; Kang, M
INVESTIG CLIN UROL 2019 10.4111/icu.2019.60.6.454
The clinical utility of transperineal template-guided saturation prostate biopsy for risk stratification after transrectal ultrasound-guided biopsy
Song1, W; Kang, M; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Jeon, HG
J ENDOUROL 2019 10.1089/end.2019.0410
Comparison by Pentafecta Criteria of Transperitoneal and Retroperitoneal Robotic Partial Nephrectomy for Large Renal Tumors
Choi1, CI; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Jeon, SS; Lee, HM; Seo, SI
CANCER RES TREAT 2019 10.4143/crt.2018.604
Atezolizumab in Patients with Pretreated Urothelial Cancer: A Korean Single-Center, Retrospective Study
Hur1, JY; Kim, Y; Kwon, GY; Kang, M; Sung, HH; Jean, HG; Jeong, BC; Seo, SI; Jean, SS; Lee, HM; Lee, SJ; Park, SH
WORLD J UROL 2019 10.1007/s00345-018-02617-2
Combination of multiparametric magnetic resonance imaging and transrectal ultrasound-guided prostate biopsies is not enough for identifying patients eligible for hemiablative focal therapy for prostate cancer
Choi1, YH; Yu, JW; Kang, MY; Sung, HH; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Jeon, HG
UROL INT 2019 10.1159/000501527
Cancer Location in Upgrading and Detection after Transperineal Template-Guided Mapping Biopsy for Patients in Active Surveillance and Negative Transrectal Ultrasonography-Guided Prostate Biopsy
Lee1, CU; Sung, SH; Jang, CT; Kang, M; Sung, HH; Jeong, BC; Il Seo, S; Jeon, SS; Lee, HM; Jeon, HG
APPL SCI-BASEL 2019 10.3390/app9152982
PROMISE CLIP Project: A Retrospective, Multicenter Study for Prostate Cancer that Integrates Clinical, Imaging and Pathology Data
Park1, J; Rho, MJ; Park, YH; Jung, CK; Chong, Y; Kim, CS; Go, H; Jeon, SS; Kang, M; Lee, HJ; Hwang, SI; Lee, JY
INVESTIG CLIN UROL 2019 10.4111/icu.2019.60.4.227
Genomic analysis of Korean patients with advanced prostate cancer by use of a comprehensive next-generation sequencing panel and low-coverage, whole-genome sequencing
Kang1, M; Cho, E; Jang, J; Lee, J; Jeon, Y; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY; Jeon, HG
Cancer Manag Res 2019 10.2147/CMAR.S199432
Predictors of postoperative complications after robot-assisted radical cystectomy with extracorporeal urinary diversion
Lee1, CU; Kang, M; Kim, TJ; Na, JP; Sung, HH; Jeon, HG; Seo, S; Jeon, SS; Lee, HM; Jeong, BC
BMC UROL 2019 10.1186/s12894-019-0463-7
A retrospective feasibility study of biweekly docetaxel in patients with high-risk metastatic castration-naive prostate cancer
Yoon1, SE; Kim, Y; Cho, J; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY; Lee, SJ; Park, SH
eLife 2019 10.7554/eLife.43024
Epigenetic regulation of mammalian Hedgehog signaling to the stroma determines the molecular subtype of bladder cancer
Kim1, S; Kim, Y; Kong, J; Kim, E; Choi, JH; Yuk, HD; Lee, H; Kim, HR; Lee, KH; Kang, M; Roe, JS; Moon, KC; Kim, S; Ku, JH; Shin, K
PROSTATE CANCER P D 2019 10.1038/s41391-018-0088-z
Importance of androgen-deprivation therapy during enzalutamide treatment in men with metastatic castration-resistant prostate cancer following chemotherapy: results from retrospective, multicenter data
Jeong1, CW; Kang, M; Jung, SI; Kim, TH; Park, SW; Joung, JY; Jeon, SS; Hong, JH; Lee, JY; Chung, BH; Ahn, H; Kim, CS; Kwon, DD; Kwak, C
CLIN GENITOURIN CANC 2019 10.1016/j.clgc.2018.09.007
Comparison of Cancer Detection Rates Between TRUS-Guided Biopsy and MRI-Targeted Biopsy According to PSA Level in Biopsy-Naive Patients: A Propensity Score Matching Analysis
Choi1, YH; Kang, MY; Sung, HH; Eon, HG; Jeong, BC; Seo, SI; Jeon, SS; Kim, CK; Park, BK; Lee, HM
Cancer Manag Res 2019 10.2147/CMAR.S185796
Incidences and oncological outcomes of urothelial carcinoma in kidney transplant recipients
Yu1, J; Lee, CU; Kang, M; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Sung, HH
외 다수
Functions of human liver CD69(+)CD103(-)CD8(+) T cells depend on HIF-2 alpha activity in healthy and pathologic livers
Kim1, JH; Han, JW; Choi, YJ; Rha, MS; Koh, JY; Kim, KH; Kim, CG; Lee, YJ; Kim, AR; Park, J; Kim, HK; Min, BS; Il Seo, S; Kang, M; Park, HJ; Han, DH; Il Kim, S; Kim, MS; Lee, JG; Lee, DH; Kim, W; Park, JY; Park, SH; Joo, DJ; Shin, EC
INVESTIG CLIN UROL 2020 10.4111/icu.2020.61.1.19
Enzalutamide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: A retrospective Korean multicenter study in a real-world setting
Jung1, SI; Kim, MS; Jeong, CW; Kwak, C; Hong, SK; Kang, SH; Joung, JY; Lee, SH; Yun, SJ; Kim, TH; Park, SW; Jeon, SS; Kang, M; Lee, JY; Chung, BH; Hong, JH; Ahn, H; Kim, CS; Kwon, DD
CLIN GENITOURIN CANC 2019 10.1016/j.clgc.2019.07.014
Novel Predictive Models of Early Death Less Than 1 Year in Patients With Metastatic Renal Cell Carcinoma After Treatment With First-line Tyrosine Kinase Inhibitors
Shin1, SJ; Kim, T; Sung, HH; Jeon, HG; Jeong, BC; Park, SH; Jeon, SS; Lee, HM; Choi, HY; Seo, SI; Kang, M
INVESTIG CLIN UROL 2019 10.4111/icu.2019.60.6.454
The clinical utility of transperineal template-guided saturation prostate biopsy for risk stratification after transrectal ultrasound-guided biopsy
Song1, W; Kang, M; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Jeon, HG
J ENDOUROL 2019 10.1089/end.2019.0410
Comparison by Pentafecta Criteria of Transperitoneal and Retroperitoneal Robotic Partial Nephrectomy for Large Renal Tumors
Choi1, CI; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Jeon, SS; Lee, HM; Seo, SI
CANCER RES TREAT 2019 10.4143/crt.2018.604
Atezolizumab in Patients with Pretreated Urothelial Cancer: A Korean Single-Center, Retrospective Study
Hur1, JY; Kim, Y; Kwon, GY; Kang, M; Sung, HH; Jean, HG; Jeong, BC; Seo, SI; Jean, SS; Lee, HM; Lee, SJ; Park, SH
WORLD J UROL 2019 10.1007/s00345-018-02617-2
Combination of multiparametric magnetic resonance imaging and transrectal ultrasound-guided prostate biopsies is not enough for identifying patients eligible for hemiablative focal therapy for prostate cancer
Choi1, YH; Yu, JW; Kang, MY; Sung, HH; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Jeon, HG
UROL INT 2019 10.1159/000501527
Cancer Location in Upgrading and Detection after Transperineal Template-Guided Mapping Biopsy for Patients in Active Surveillance and Negative Transrectal Ultrasonography-Guided Prostate Biopsy
Lee1, CU; Sung, SH; Jang, CT; Kang, M; Sung, HH; Jeong, BC; Il Seo, S; Jeon, SS; Lee, HM; Jeon, HG
APPL SCI-BASEL 2019 10.3390/app9152982
PROMISE CLIP Project: A Retrospective, Multicenter Study for Prostate Cancer that Integrates Clinical, Imaging and Pathology Data
Park1, J; Rho, MJ; Park, YH; Jung, CK; Chong, Y; Kim, CS; Go, H; Jeon, SS; Kang, M; Lee, HJ; Hwang, SI; Lee, JY
INVESTIG CLIN UROL 2019 10.4111/icu.2019.60.4.227
Genomic analysis of Korean patients with advanced prostate cancer by use of a comprehensive next-generation sequencing panel and low-coverage, whole-genome sequencing
Kang1, M; Cho, E; Jang, J; Lee, J; Jeon, Y; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY; Jeon, HG
Cancer Manag Res 2019 10.2147/CMAR.S199432
Predictors of postoperative complications after robot-assisted radical cystectomy with extracorporeal urinary diversion
Lee1, CU; Kang, M; Kim, TJ; Na, JP; Sung, HH; Jeon, HG; Seo, S; Jeon, SS; Lee, HM; Jeong, BC
BMC UROL 2019 10.1186/s12894-019-0463-7
A retrospective feasibility study of biweekly docetaxel in patients with high-risk metastatic castration-naive prostate cancer
Yoon1, SE; Kim, Y; Cho, J; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY; Lee, SJ; Park, SH
eLife 2019 10.7554/eLife.43024
Epigenetic regulation of mammalian Hedgehog signaling to the stroma determines the molecular subtype of bladder cancer
Kim1, S; Kim, Y; Kong, J; Kim, E; Choi, JH; Yuk, HD; Lee, H; Kim, HR; Lee, KH; Kang, M; Roe, JS; Moon, KC; Kim, S; Ku, JH; Shin, K
PROSTATE CANCER P D 2019 10.1038/s41391-018-0088-z
Importance of androgen-deprivation therapy during enzalutamide treatment in men with metastatic castration-resistant prostate cancer following chemotherapy: results from retrospective, multicenter data
Jeong1, CW; Kang, M; Jung, SI; Kim, TH; Park, SW; Joung, JY; Jeon, SS; Hong, JH; Lee, JY; Chung, BH; Ahn, H; Kim, CS; Kwon, DD; Kwak, C
CLIN GENITOURIN CANC 2019 10.1016/j.clgc.2018.09.007
Comparison of Cancer Detection Rates Between TRUS-Guided Biopsy and MRI-Targeted Biopsy According to PSA Level in Biopsy-Naive Patients: A Propensity Score Matching Analysis
Choi1, YH; Kang, MY; Sung, HH; Eon, HG; Jeong, BC; Seo, SI; Jeon, SS; Kim, CK; Park, BK; Lee, HM
Cancer Manag Res 2019 10.2147/CMAR.S185796
Incidences and oncological outcomes of urothelial carcinoma in kidney transplant recipients
Yu1, J; Lee, CU; Kang, M; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Sung, HH
외 다수
저서
저서 내용이 없습니다.
보도자료
보도자료 내용이 없습니다.
포스팅
포스팅 내용이 없습니다.
영상자료
영상자료 내용이 없습니다.
발표자료
발표자료 내용이 없습니다.